Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Thromboembolic and Hemorrhagic Risk Evaluation in Surgically Treated Patients With CSDH Taking Anticoagulants and Antithrombotics

NCT05079295 is registered in ClinicalTrials.gov with University Hospital of Ferrara as lead sponsor.

NCT NCT05079295
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05079295 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Thromboembolic and Hemorrhagic Risk Evaluation in Surgically Treated Patients With CSDH Taking Anticoagulants and Antithrombotics
Lead sponsor
University Hospital of Ferrara
Phase
Observational
Overall status
Unknown status
Start date
February 20, 2021
Completion date
February 20, 2024
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulant-induced bleeding, cardiovascular stroke, chronic subdural hematoma, thromboembolic stroke